electromotive drug administration Latest Research Papers

Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of high-grade nonmuscle invasive bladder cancer after BCG failure

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2020.06.031 ◽

2020 ◽

Vol 38 (11) ◽

pp. 850.e9-850.e15 ◽

Cited By ~ 2

Author(s):

Tristan Juvet ◽

Andrea Mari ◽

Katherine Lajkosz ◽

Christopher JD Wallis ◽

Cynthia Kuk ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Drug Administration ◽

Invasive Bladder Cancer ◽

High Grade ◽

Bacillus Calmette Guerin ◽

Sequential Administration ◽

Bcg Failure ◽

Electromotive Drug Administration ◽

Nonmuscle Invasive Bladder Cancer

Download Full-text

Botulinum Toxin Type A Therapy: Intravesical Injection or Electromotive Drug Administration

Urology ◽

10.1016/j.urology.2020.04.104 ◽

2020 ◽

Vol 142 ◽

pp. 190-194 ◽

Cited By ~ 1

Author(s):

Seyedeh-Sanam Ladi-Seyedian ◽

Lida Sharifi-Rad ◽

Abdol-Mohammad Kajbafzadeh

Keyword(s):

Botulinum Toxin ◽

Drug Administration ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Intravesical Injection ◽

Electromotive Drug Administration

Download Full-text

MP73-01 SEQUENTIAL ADMINISTRATION OF BACILLUS CALMETTE-GUERIN (BCG) AND ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) OF MITOMYCIN C (MMC) FOR THE TREATMENT OF HIGH GRADE NON MUSCLE INVASIVE BLADDER CANCER AFTER BCG FAILURE

The Journal of Urology ◽

10.1097/ju.0000000000000959.01 ◽

2020 ◽

Vol 203 ◽

pp. e1121

Author(s):

Tristan Juvet* ◽

Christopher Wallis ◽

Lior Krimus ◽

Cynthia Kuk ◽

Annette Erlich ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Drug Administration ◽

High Grade ◽

Bacillus Calmette Guerin ◽

Muscle Invasive Bladder Cancer ◽

Sequential Administration ◽

Bcg Failure ◽

Muscle Invasive ◽

Electromotive Drug Administration

Download Full-text

Correspondence: Efficacy of electromotive drug administration in delivering botulinum toxin A in children with neuropathic detrusor overactivity – outcomes of a pilot study

Journal of Pediatric Urology ◽

10.1016/j.jpurol.2020.01.010 ◽

2020 ◽

Vol 16 (2) ◽

pp. 265-266

Author(s):

Behnam Nabavizadeh ◽

Lida Sharifi-Rad ◽

Seyedeh-Sanam Ladi-Seyedian ◽

Abdol-Mohammad Kajbafzadeh

Keyword(s):

Botulinum Toxin ◽

Pilot Study ◽

Drug Administration ◽

Detrusor Overactivity ◽

Botulinum Toxin A ◽

Toxin A ◽

Electromotive Drug Administration

Download Full-text

Applications of electromotive drug administration in urology

Urology Annals ◽

10.4103/ua.ua_152_19 ◽

2020 ◽

Vol 12 (4) ◽

pp. 301

Author(s):

Sachin Malde ◽

Safiya Hashemi ◽

Arun Sahai

Keyword(s):

Drug Administration ◽

Electromotive Drug Administration

Download Full-text

Efficacy of electromotive drug administration in delivering botulinum toxin a in children with neuropathic detrusor overactivity—outcomes of a pilot study

Journal of Pediatric Urology ◽

10.1016/j.jpurol.2019.05.028 ◽

2019 ◽

Vol 15 (5) ◽

pp. 552.e1-552.e8 ◽

Cited By ~ 3

Author(s):

C. Koh ◽

C.V. Melling ◽

C. Jennings ◽

M. Lewis ◽

A. Goyal

Keyword(s):

Botulinum Toxin ◽

Pilot Study ◽

Drug Administration ◽

Detrusor Overactivity ◽

Botulinum Toxin A ◽

Toxin A ◽

Electromotive Drug Administration

Download Full-text

Intravesical sequential BCG/electromotive drug administration Mitomycin C (EMDA-MMC) in patients with primitive and recurrent high risk non muscle invasive bladder cancer

European Urology Supplements ◽

10.1016/s1569-9056(19)33635-8 ◽

2019 ◽

Vol 18 (9) ◽

pp. e3249

Author(s):

F. Di Modugno ◽

S. Forte ◽

V. Pagliarulo ◽

G. Lucarelli ◽

V. Pastoressa ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Drug Administration ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Electromotive Drug Administration

Download Full-text

Will long-term disease specific outcomes of bladder conservation with sequential Bacillus Calmette-Guérin (BCG) and electromotive drug administration Mitomycin-C (EMDA-MMC) for high-risk non-muscle invasive bladder cancer (HR-NMIBC) influence adoption?

Frontiers in Oncology ◽

10.3389/conf.fonc.2019.01.00015 ◽

2019 ◽

Vol 9 ◽

Author(s):

Jennifer Lane ◽

Zakariya Abdille ◽

Christine Gan ◽

Kathryn Chatterton ◽

Suzanne Amery ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Drug Administration ◽

Bacillus Calmette Guerin ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Electromotive Drug Administration ◽

Disease Specific

Download Full-text

ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes

BMC Cancer ◽

10.1186/s12885-018-5134-7 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 11

Author(s):

Marco Racioppi ◽

Luca Di Gianfrancesco ◽

Mauro Ragonese ◽

Giuseppe Palermo ◽

Emilio Sacco ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Salvage Therapy ◽

First Line ◽

Muscle Invasive Bladder Cancer ◽

Bcg Failure ◽

Muscle Invasive ◽

Electromotive Drug Administration

Download Full-text

Intravesical sequential BCG/electromotive drug administration Mitomycin C (EMDA-MMC) in high risk non muscle invasive bladder cancer – results from a retrospective analysis

European Urology Supplements ◽

10.1016/s1569-9056(18)33383-9 ◽

2018 ◽

Vol 17 (8) ◽

pp. 357-358

Author(s):

F. Di Modugno ◽

V. Pagliarulo ◽

A. Procacci ◽

F. Bianchi ◽

S. Tafuri ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Retrospective Analysis ◽

Mitomycin C ◽

Drug Administration ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Electromotive Drug Administration

Download Full-text

electromotive drug administration
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of high-grade nonmuscle invasive bladder cancer after BCG failure

Botulinum Toxin Type A Therapy: Intravesical Injection or Electromotive Drug Administration

MP73-01 SEQUENTIAL ADMINISTRATION OF BACILLUS CALMETTE-GUERIN (BCG) AND ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) OF MITOMYCIN C (MMC) FOR THE TREATMENT OF HIGH GRADE NON MUSCLE INVASIVE BLADDER CANCER AFTER BCG FAILURE

Correspondence: Efficacy of electromotive drug administration in delivering botulinum toxin A in children with neuropathic detrusor overactivity – outcomes of a pilot study

Applications of electromotive drug administration in urology

Efficacy of electromotive drug administration in delivering botulinum toxin a in children with neuropathic detrusor overactivity—outcomes of a pilot study

Intravesical sequential BCG/electromotive drug administration Mitomycin C (EMDA-MMC) in patients with primitive and recurrent high risk non muscle invasive bladder cancer

Will long-term disease specific outcomes of bladder conservation with sequential Bacillus Calmette-Guérin (BCG) and electromotive drug administration Mitomycin-C (EMDA-MMC) for high-risk non-muscle invasive bladder cancer (HR-NMIBC) influence adoption?

ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes

Intravesical sequential BCG/electromotive drug administration Mitomycin C (EMDA-MMC) in high risk non muscle invasive bladder cancer – results from a retrospective analysis

Export Citation Format

electromotive drug administrationRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of high-grade nonmuscle invasive bladder cancer after BCG failure

Botulinum Toxin Type A Therapy: Intravesical Injection or Electromotive Drug Administration

MP73-01 SEQUENTIAL ADMINISTRATION OF BACILLUS CALMETTE-GUERIN (BCG) AND ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) OF MITOMYCIN C (MMC) FOR THE TREATMENT OF HIGH GRADE NON MUSCLE INVASIVE BLADDER CANCER AFTER BCG FAILURE

Correspondence: Efficacy of electromotive drug administration in delivering botulinum toxin A in children with neuropathic detrusor overactivity – outcomes of a pilot study

Applications of electromotive drug administration in urology

Efficacy of electromotive drug administration in delivering botulinum toxin a in children with neuropathic detrusor overactivity—outcomes of a pilot study

Intravesical sequential BCG/electromotive drug administration Mitomycin C (EMDA-MMC) in patients with primitive and recurrent high risk non muscle invasive bladder cancer

Will long-term disease specific outcomes of bladder conservation with sequential Bacillus Calmette-Guérin (BCG) and electromotive drug administration Mitomycin-C (EMDA-MMC) for high-risk non-muscle invasive bladder cancer (HR-NMIBC) influence adoption?

ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes

Intravesical sequential BCG/electromotive drug administration Mitomycin C (EMDA-MMC) in high risk non muscle invasive bladder cancer – results from a retrospective analysis

electromotive drug administration
Recently Published Documents